Summary
The development of a practical screening procedure for phenylketonuria and the improvement in methods of chemical analysis have led to a realization that Folling's (1934) disease of phenylketonuria is not a single entity.
In this commentary, the current view on some aspects of phenylketonuria will be reviewed and the problems illustrated by experience gained in the Phenylketonuria Clinic at the Royal Alexandra Hospital for Children in Sydney, at present attended by fifty-six children. From April 1964, fifty-six infants and children were referred because of a positive screening test. Six were no longer abnormal at the time of retesting, forty-two had classical phenylketonuria and eight showed an atypical pattern. Subsequent family studies revealed five other classical phenylketonuric children, all of whom were retarded, and one other atypical phenylketonuric boy. Screening surveys and the establishment of a chemical diagnosis It is widely held that a low phenylalanine diet is responsible for the encouraging results in infants with phenylketonuria treated early Fuller, 1967; Kennedy et al., 1967) and that this improvement is not solely due to the inclusion of infants who would otherwise have shown good intellectual attainments without restrictions, as Bessman has suggested (1966) . If we accept the efficacy of treatment then it is important to make the diagnosis and to start dietary treatment as early as possible. There is no evidence that the lowering of serum phenylalanine levels influences any existing neurological damage or intellectual deficit (Woolf et al., 1958) , though aspects of behaviour may be modified. If the diagnosis of phenylketonuria is to be made before the onset of signs and symptoms, all newborn infants must be routinely screened.
The present state of screening procedures has been well reviewed by Woolf (1968) . Screening procedures available are listed in Table 1 . Methods using wet urine samples have proven overwhelmingly difficult in the collection of the specimen (Gibbs & Woolf, 1959) . The use of a proprietary ferric chloride buffered test strip ('Phenistix') whilst avoiding some of (Armstrong et al., 1961) and atypical cases with mildly elevated serum phenylalanine levels. Filter paper urine examined by chromatographic methods is useful and is widely employed Turner & Brown, 1967) . Capillary blood samples collected on filter paper and dried will detect even mild cases of hyperphenylalaninaemia. The specimens are generally assayed by a microbiological inhibition technique (Guthrie & Susi, 1963) , but more recently fluorometric methods have been used (Searle et al., 1967 (Turner & Brown, 1967 (Cawte, 1957; Davidson & Sandler, 1958) .
(ii) Phenylalanine transaminase defect Phenylketonuria with associated phenylalanine transaminase defects has been described by Anderson et al. (1966) and Auerbach, Di George & Carpenter (1967 (iv) Atypical phenylketonuria The remaining infants of our series fall into the so called 'atypical' group.
These infants have elevated serum phenylalanine levels of 4-20 mg per 100 ml, but the levels are not as high as those reached in classical phenylketonuria (Hsia, O'Flynn & Berman, 1968 Woolf et al., 1968; Hsia, O'Flynn & Berman, 1968) .
Serum aminoacid levels are higher on the foetal side than the maternal side of the placenta as phenylalanine actively crosses the placenta, as do the other aminoacids. The high serum phenylalanine levels of the mother with phenylketonuria will be reflected in the foetal serum levels and in the newly born infant immediately after birth. Guthrie testing may reveal this passively acquired abnormality even though it be a transient phenomenon (Denniston, 1963 (Auerbach et al., 1967) .
The problems of a low phenylalanine diet fall into two main groups: (i) the maintenance of adequate nutrition and growth.
(ii) the management of the emotional difficulties of the patient and his family.
Phenylalanine is an essential aminoacid and its requirements vary with age and growth. Phenylalanine deficiency is characterized by failure of weight gain, rash in the nappy area, anorexia, lethargy, listlessness (Medical Research Council, 1963) and alopecia (Pitt, 1967) . Phenylalanine requirements are higher in early infancy per unit weight than later life. Growth requirements increase rapidly over the first months of life (Snyderman et al., 1955; Kennedy et al., 1967) Dietary deficiencies of folic acid (Royston & Parry, 1962) and choline (Wilson & Clayton, 1962) have been reported with low phenylalanine diets. Brown & Waisman (1967) Table 5 . (Justice et al., 1967) .
The mechanism of brain damage remains unknown, but seems to be related to a level of serum phenylalanine of 20 mg/100 ml which remains a useful upper limit of safety (Hsia et al., 1968) . Most workers prefer their treated children to have levels less than 10-12 mg/100 ml (Baumeister, 1967; McBean & Stephenson, 1968) . The management of atypical cases varies markedly. Berry et al. (1967) treat their children when the serum phenylalanine level exceeds 15 mg/100 ml. Kennedy et al. (1967) treat all infants with initial fasting levels greater than 12 mg/100 ml while Auerbach et al. (1967) only treat atypicals who excrete phenylpyruvic acid in excess of 15 mg/100 ml, or who maintain serum phenylalanine levels around 30 mg/100 ml. Many would not accept this last group as having the atypical form of the disease.
Atypical phenylketonurics in this clinic are treated with a low phenylalanine diet if their initial fasting serum phenylalanine level is over 15 mg/100 ml or if, after an oral load, the 4-hr phenylalanine level is still over 15 mg/100 ml. Typical tolerance tests in three atypical infants are shown in Table 3 . Two infants (C.L. and J.G.) had safe initial serum phenylalanine levels, but after an oral load of 1-phenylalanine 100 mg/kg body weight, the level exceeded 20 mg/100 ml at 1 hr and after 4 hr was still in excess of 20 mg/ 100 ml.
The average loading test in a neonate is equivalent to 2-3 times the phenylalanine load in a half strength cow's milk feeding of 100 ml and so does not repre- Woolf, 1962; Poser & Van Bogaert, 1959; Crome, 1962) or with the constitution of cerebral lipid (Foote et al., 1965; Menkes, 1966; Menkes & Aeberhard, 1969) , then it would seem reasonable to stop the diet when brain growth is complete or myelinization is complete. Alternative mechanisms suggested as a cause of retardation are disordered 5-hydroxytryphophane metabolism (McKean, Schanberg & Giarman, 1962) or interference with aminoacid transport (Neame, 1961 (Clayton et al., 1966) .
Clinical impressions in other centres also suggest that children who are already brain-damaged to some degree may benefit from long-term dietary modifications if not strict dietary restrictions (Langdell, 1965) . Such children in this clinic are kept on a largely vegetarian diet with protein supplied in the form of a low phenylalanine milk. There is no strict control of the quantity of low phenylalanine foods eaten by these children.
The foregoing principles may not hold for otherwise normal phenylketonuric children with normal development and intelligence. Some fifty to sixty children have had their diets terminated at 3-6 years and with rare exceptions no neurological, psychological, intellectual or behavioural changes have been noted (Berry & Wright, 1967; Hackney et al., 1968) . No subsequent reports have appeared which record any deterioration when diets are suspended in the otherwise normal child in the 3-6 years age group. Reports of increased irritability, restlessness, distractibility or autistic behaviour have generally occurred in children already showing minimal disabilities (Koch et al., 1964) . It seems likely that a phenylketonuric child with evidence of brain damage may need dietary restrictions for a longer period than the otherwise normal phenylketonuric child.
Maternal phenylketonuria
Mass screening programmes and early dietary management will increase the number of homozygous phenylketonuric women in the community who are of normal intelligence and in the childbearing age.
References to the children of phenylketonuric mothers were made in the early literature, but it was not till the report of Mabry et al. (1966) that the full implications of maternal phenylketonuria on the offspring were appreciated. Recently the subject was reviewed by . They found that sixty-five of the sixty-eight reported children were retarded, twenty-eight were microcephalic, eight of their twelve children suffered from epilepsy. Stevenson & Huntley (1967) found a high incidence of congenital heart lesions, notably septal defects, and a high incidence of abortions and low birthweight infants in the affected families. Clearly, the maternal disease and the resulting high phenylalanine environment to which the foetus is exposed are much more serious than previously thought.
There is one reported case of a phenylketonuric woman being placed on a restricted diet during pregnancy (Allan & Brown, 1968) . The diet is said to have been given before pregnancy and then again in the last 5 months; no details are given about the diet in the early pregnancy. The infant resulting from this pregnancy appeared normal at 9 months of age.
The microcephaly, cardiac septal anomalies, frequent abortions and low birth-weight infants suggest that the factors responsible commence to have an effect early in pregnancy and continue to do so throughout intrauterine life.
Pregnancy is often difficult to diagnose in the early months, yet this is the stage at which the foetus may be most easily damaged by teratogens, in this case, phenylalanine or one of its metabolites.
A confident prognosis for the children of phenylketonuric mothers can only be given if the serum levels are controlled from the time of conception. As human vagaries preclude life-long dietary restrictions in these women, planned pregnancies and dietary restrictions during the fertile period and any subsequent pregnancy appear to be the only satisfactory method of management.
The supervision of these women and the meticulous control of all aspects of their diet will present the major challenge in the management of phenylketonuria in the next decade.
